Pregled bibliografske jedinice broj: 938714
Pharmacology, pharmacokinetics and tissue disposition of zwitterionic hydroxyiminoacetamido alkylamines as reactivating antidotes for organophosphate exposure
Pharmacology, pharmacokinetics and tissue disposition of zwitterionic hydroxyiminoacetamido alkylamines as reactivating antidotes for organophosphate exposure // The Journal of pharmacology and experimental therapeutics, 367 (2018), 2; 363-372 doi:10.1124/jpet.118.249383 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 938714 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Pharmacology, pharmacokinetics and tissue disposition of zwitterionic hydroxyiminoacetamido alkylamines as reactivating antidotes for organophosphate exposure
Autori
Sit, Rakesh K. ; Kovarik, Zrinka ; Maček Hrvat, Nikolina ; Žunec, Suzana ; Green, Carol ; Fokin, Valery V. ; Sharpless, K. Barry ; Radić, Zoran ; Taylor, Palmer
Izvornik
The Journal of pharmacology and experimental therapeutics (0022-3565) 367
(2018), 2;
363-372
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
acetylcholinesterase ; organophosphates ; oxime reactivators ; blood-brain barrier
Sažetak
In the development of antidotal therapy for treatment of organophosphate exposure from pesticides used in agriculture and nerve agents insidiously used in terrorism, the methylpyridinium aldoximes have received primary attention since their early development by I.B. Wilson in the 1950's. Yet these agents, by virtue of their quaternary structure, are limited in crossing the blood-brain barrier, and require administration parenterally to achieve full distribution in the body. Oximes lacking cationic charges or presenting a tertiary amine have been considered as alternatives. Herein, we examine the pharmacokinetic properties in the mouse of a lead ionizable, zwitterionic hydroxyiminoacetamido alkylamine to develop a framework for studying these agents in vivo and generate sufficient data for their consideration as appropriate antidotes for humans. Consequently, in vitro and in vivo efficacies of immediate structural congeners were explored to feasible backups for animal studies. We have compared oral and parenteral dosing, and developed an intramuscular loading and oral maintenance dosing scheme in mice. Steady-state plasma and brain levels of the antidote are achieved with sequential administration out to 10 hours, with brain exceeding plasma levels shortly after administration. Moreover, the zwitterionic oxime shows substantial protection after gastric lavage, whereas the classic methylpyridinium aldoxime, 2-PAM, is without evident protection. While further studies in other animal species are necessary, ionizing zwitterionic aldoximes present viable alternatives to existing antidotes for prophylaxis and treatment of large numbers of individuals in terrorist-led events with nerve agent organophosphates, such as sarin, and in organophosphate pesticide exposure.
Izvorni jezik
Engleski
Znanstvena područja
Kemija
POVEZANOST RADA
Projekti:
HRZZ-IP-2013-11-4307 - Dizajn, sinteza i evaluacija novih protuotrova kod trovanja živčanim bojnim otrovima i pesticidima (CHOLINESTERASE) (Kovarik, Zrinka, HRZZ - 2013-11) ( CroRIS)
Ustanove:
Institut za medicinska istraživanja i medicinu rada, Zagreb
Profili:
Suzana Žunec
(autor)
Zoran Radić
(autor)
Nikolina Macek Hrvat
(autor)
Zrinka Kovarik
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE